Edit or reportability question

[Deborah Towell]

An edit issue has been referred to us. We cannot find clear directions on reportability so not sure if it is an edit issue or maybe this is not reportable. I hope you can help.

Here is the path text:
7/29/16 RIGHT TUBE AND OVARY. ATYPICAL PROLIFERATION (BORDERLINE) MUCINOUS TUMOR 19 CM WITH INTRAEPITHELIAL CA. INVASIVE ADENOCA NOT IDENTIFIED. (ONLY IN SITU REPORTABLE) CAPSULE INTACT. NEG OVARIAN SURFACE INVOLVEMENT. LEFT TUBE AND OVARY NEG. OMENTUM NEG.

Here is the edit:

TNM Groups Not Stageable – Insitu (CoC)
M: TNM Chapter: 37A
Date of Diagnosis (530) = Y:2016 M:07 D:29
Primary Site (540) = C569
Histologic Type ICD-O-3 (550) = 8010
Behavior Code ICD-O-3 (554) = 2
TNM Clin T (958) = <BLANK>
TNM Clin N (962) = <BLANK>
TNM Clin M (966) = <BLANK>
TNM Clin Stage Group (970) = 99
TNM Path T (940) = <BLANK>
TNM Path N (944) = <BLANK>
TNM Path M (948) = <BLANK>
TNM Path Stage Group (952) = 99
Age at Diagnosis (193) = 054
CS Site-Specific Factor10 (1030) = 988
CS Site-Specific Factor25 (1075) = 988
Grade (555) = 9
Sex (192) = 2
Type of Reporting Source (563) = 1

Any information would be greatly appreciated.

Thank you,

[Jim Hofferkamp]

The “intraepithelial carcinoma” is reportable and the registrar coded it correctly (8010/2). There is a SEER SINQ post that confirms this.

If you look in your AJCC manual in the ovary chapter (pg 419), you’ll see that there isn’t a stage group 0 (in situ). Since there is not a stage group for this site/histology combination, it is appropriate to enter 88 in the T, N, M and stage group data items.

I really don’t think this has received enough attention in the educational materials (at least not in the NAACCR webinars). I will make sure this coding instruction does get included in upcoming webinars.

[Author]

Posts